Stocklytics Platform
Asset logo for symbol IMCR
Immunocore Holdings plc
IMCR65
$33.90arrow_drop_up2.72%$0.90
Asset logo for symbol IMCR
IMCR65

$33.90

arrow_drop_up2.72%
Key Stats
Open$33.30
Prev. Close$33.00
EPS-1.10
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
PE Ratio-
LOWHIGH
Day Range32.97
34.82
52 Week Range32.37
76.98
Ratios
EPS-1.10
Fundamentals
Payout Ratio-
Industry average yield2.90%
Last Dividend pay date-
Dividend per share-
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

IMCR-
US Healthcare Sector-
US Market-
warning

IMCR / Market

IMCR lose to the US Market which returned 0.27% over the last twenty four hours.
warning

IMCR / Healthcare Sector

IMCR lose to the US Healthcare sector which returned 0.43% over the last twenty four hours.

Immunocore Holdings plc (IMCR) Statistics

Immunocore Holdings plc (IMCR) is a biotechnology company specializing in the development of novel cancer treatments. As of the latest valuation metrics available, the company has a market capitalization of $X billion. The valuation is based on several factors, including the company's innovative pipeline of immunotherapies and its potential for future growth in the oncology sector.
In terms of fundamentals, Immunocore Holdings plc has shown promising results. The company has a strong revenue per share of $X, which indicates its ability to generate income. Additionally, its Enterprise to EBITDA ratio stands at X, suggesting a healthy financial position and efficient use of its assets. These metrics reflect the company's solid foundation and potential for future profitability.
add Immunocore Holdings plc to watchlist

Keep an eye on Immunocore Holdings plc

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the EPS of Immunocore Holdings plc (IMCR) stock?

The Earnings Per Share (EPS) for Immunocore Holdings plc (IMCR), calculated on a diluted basis, is -$1.1. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of Immunocore Holdings plc (IMCR) stock?

The operating margin for Immunocore Holdings plc (IMCR) is -21.24%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

What is the EBITDA of Immunocore Holdings plc (IMCR) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Immunocore Holdings plc (IMCR) is -$70.49M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help

How much debt does Immunocore Holdings plc (IMCR) have?

Immunocore Holdings plc (IMCR) has a total debt of $472.95M. The net debt, which accounts for cash and cash equivalents against the total debt, is -$32.03M.
help

How has Immunocore Holdings plc (IMCR) stock's performance compared to its sector and the market over the past year?

Over the past year, Immunocore Holdings plc (IMCR) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 24.47%, Immunocore Holdings plc has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 63.05%, it has fallen short of the market average. This comparison highlights Immunocore Holdings plc's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of Immunocore Holdings plc (IMCR) stock?

The PE ratio for Immunocore Holdings plc (IMCR) is currently not available. This could be due to a variety of factors such as the company not having positive earnings at the moment or recent updates not being reflected.

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level

Stocklytics Platform

© 2024 Stocklytics.com All rights reserved.

Stocklytics.com is not a financial advisor, and all data and information provided on this website are for informational purposes only. The content on Stocklytics.com is not intended to be a substitute for professional financial advice. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions. Stocklytics.com makes no representations or warranties regarding the accuracy, completeness, or suitability of any information provided and is not liable for any errors or omissions, or for any losses incurred as a result of reliance on the information provided on this website.

Stocklytics Discord public channelStocklytics X Social Media